Imran Zoberi, Md

Imran Zoberi, MD

Siteman Cancer Center

Meet Tasnim Imran, MD

Brown University Health

Transforming therapy for patients with relapsed myeloma: the era of bispecific antibodies

VJHemOnc – Video Journal of Hematology & HemOnc

Imran Kazem, MD, Radiology, Arnett

Panel Discusses Use of Bispecifics to Treat Relapsed/Refractory Myeloma, Toxicity Considerations

Blood Cancers Today

Addressing the disparities in myeloma care

VJHemOnc – Video Journal of Hematology & HemOnc

What is the next big breakthrough in cancer research?

Damon Runyon Cancer Research Foundation

The patients’ perspective and advocacy in the fight against myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Hisham Seify - CELLULAR REPAIR™ Post-Op Protocol to Enhance Recovery After Plastic Surgery

Clinical Research in the Treatment of Pancreas Cancer

Meet Arnab Chakravarti, MD, Radiation Oncologist at the OSUCCC – James

Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute

MMprofiler with SKY92 Combined with ISS to Identify Risk Status in Multiple Myeloma

Targeted Oncology

Omar F. Ishaq, MD, Radiation Oncology

The importance of imaging for patients with high-risk disease

VJHemOnc – Video Journal of Hematology & HemOnc

First results of CAR-PRISM: early safety and efficacy of CAR-T in high-risk smoldering myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Edward Babiarz speaks about his treatment at Fox Chase

Fox Chase Cancer Center

An update on the RADAR trial: RCyBorD as induction therapy in newly diagnosed multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Oncologic Imaging in the Era of Immunotherapy

Yale Radiology and Biomedical Imaging

Evolving Myeloma Treatment Options | Bispecific Antibody Therapy

Patient Empowerment Network

Dr. Brian Gazzard - Clinical Research Director, HIV. Chelsea and Westminster Hospital, London.

RDI